Formulation and optimization of simvastatin loaded nanostructured lipid carriers using central composite design

Nikhila  Subramanyam; Haranath Chinthaginjala; Bhargavi  Dasari; Priya Gogula; Maheswar Reddy Yaga

doi:10.69857/joapr.v14i1.1517

Authors

Subramanyam Nikhila Department of Pharmaceutics, Raghavendra Institute of Pharmaceutical Education and Research (RIPER)- Autonomous, KR palli cross, Chiyyedu post, Ananthapuramu, 515721, Andhra Pradesh, India
Haranath Chinthaginjala Department of Pharmaceutics, Raghavendra Institute of Pharmaceutical Education and Research (RIPER)- Autonomous, KR palli cross, Chiyyedu post, Ananthapuramu, 515721, Andhra Pradesh, India
Dasari Bhargavi Department of Pharmaceutics, Raghavendra Institute of Pharmaceutical Education and Research (RIPER)- Autonomous, KR palli cross, Chiyyedu post, Ananthapuramu, 515721, Andhra Pradesh, India
Gogula Priya Department of Pharmaceutics, Raghavendra Institute of Pharmaceutical Education and Research (RIPER)- Autonomous, KR palli cross, Chiyyedu post, Ananthapuramu, 515721, Andhra Pradesh, India
Yaga Maheswar Reddy Department of Pharmaceutics, Raghavendra Institute of Pharmaceutical Education and Research (RIPER)- Autonomous, KR palli cross, Chiyyedu post, Ananthapuramu, 515721, Andhra Pradesh, India

DOI:

https://doi.org/10.69857/joapr.v14i1.1517

Keywords:

Entrapment efficiency, Nanostructured lipid carriers, Particle size, Simvastatin, Zeta potential

Abstract

Background: This study aimed to formulate and optimize simvastatin-loaded nanostructured lipid carriers using central composite design. The concentrations of stearic acid, olive oil, and surfactant were designated as independent variables. The dependent variables nominated were particle size, zeta potential, and % entrapment efficiency. Methodology: Simvastatin-loaded nanostructured lipid carriers were prepared using the solvent-injection method. Polynomial equations were used to forecast the quantifiable impact of independent factors at various levels on response variables. It was found that the curvature effect was substantial and that the model was nonlinear. To optimize, the study employed the central composite design. Results & Discussions: Studies using DSC and FT-IR showed that the drug and excipients were compatible. The particle size, polydispersity index, and zeta potential values of all formulations were within the range of 133.8-460.7 nm, 0.215-0.460, and -28.3 to -32.1, respectively. The study's outcomes confirmed that olive oil significantly affects particle size and % entrapment efficiency. The relationships between the independent variables and the dependent variables were elucidated using contour plots. The experimental results and the model's predicted values were reasonably close; the statistical model can be considered mathematically valid. Conclusion: The outcomes confirmed the efficacy of the proposed design for developing simvastatin-loaded nanostructured lipid carriers with optimized properties.

Downloads

Download data is not yet available.

References

Akbari J, Saeedi M, Ahmadi F, Hashemi SM, Babaei A, Yaddollahi S, Rostamkalaei SS, Asare-Addo K, Nokhodchi A. Solid lipid nanoparticles and nanostructured lipid carriers: A review of the methods of manufacture and routes of administration. Pharm Dev Technol., 27, 525-44 (2022) https://doi.org/10.1080/10837450.2022.2084554.

Chinthaginjala H, Bogavalli V, Hindustan AA, Pathakamuri J, Pullaganti SS, Gowni A, Baktha B. Nanostructured lipid carriers: a potential era of drug delivery systems. Ind. J. Pharm. Edu. Res., 58, 21-33 (2024) https://doi.org/10.5530/ijper.58.1.3.

Vuu YM, Kadar Shahib A, Rastegar M. The potential therapeutic application of simvastatin for brain complications and mechanisms of action. Pharmaceuticals., 16, 914 (2023) https://doi.org/10.3390/ph16070914.

Abd-Elghany AE, El-Garhy O, Fatease AA, Alamri AH, Abdelkader H. Enhancing oral bioavailability of simvastatin using uncoated and polymer-coated solid lipid nanoparticles. Pharmaceutics., 16, 763(2024) https://doi.org/10.3390/pharmaceutics16060763.

Li JJ, Liu HH, Wu NQ, Yeo KK, Tan K, Ako J, Krittayaphong R, Tan RS, Aylward PE, Baek SH, Dalal J. Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects. Expert Opin Drug Metab Toxicol., 16, 837-51 (2020) https://doi.org/10.1080/17425255.2020.1802426.

Malviya V, Pande S. A Review of the Most Recent Research on Solid Lipid Nanoparticles, Focusing on Active Compound Encapsulation. Res J Pharm Technol., 18, 1658-62 (2025) https://doi.org/10.52711/0974-360x.2025.00237.

Sabale V, Jiwankar M. Nanostructured lipid carriers: An approach to oral delivery of drugs. Res J Pharm Technol., 17, 2427-30 (2024) https://doi.org/10.52711/0974-360x.2024.00380.

Lee SH, Kim JK, Jee JP, Jang DJ, Park YJ, Kim JE. Quality by Design (QbD) application for the pharmaceutical development process. J Pharm Investig., 5, 649-82 (2022) https://doi.org/10.1007/s40005-022-00575-x

Chinthaginjala H, Ahad HA, Srinivasa SK, Yaparla SR, Buddadasari S, Hassan JA, Pullaganti SS. Central composite design assisted formulation development and optimization of Gastroretentive floating tablets of dextromethorphan Hydrobromide. Ind J Pharm Edu Res., 57, 983-92 (2023) https://doi.org/10.5530/ijper.57.4.120.

Markova E, Taneska L, Kostovska M, Shalabalija D, Mihailova L, Glavas Dodov M, Makreski P, Geskovski N, Petrushevska M, N. Taravari A, Simonoska Crcarevska M. Design and evaluation of nanostructured lipid carriers loaded with Salvia officinalis extract for Alzheimer's disease treatment. J Biomed Mater Res B Appl Biomater., 110, 1368-90(2022) https://doi.org/10.1002/jbm.b.35006.

Chinthaginjala H, Telkar MB, Hindustan AA, Bhupalam P. Formulation development and optimization of famotidine mucoadhesive tablets by central composite design. Indian J. Pharm. Educ., 156, (2022) https://doi.org/10.5530/ijper.56.4.185.

Duong VA, Nguyen TT, Maeng HJ. Preparation of solid lipid nanoparticles and nanostructured lipid carriers for drug delivery and the effects of preparation parameters of solvent injection method. Molecules., 25, 4781 (2020) https://doi.org/10.3390/molecules25204781.

Osanlou R, Emtyazjoo M, Banaei A, Hesarinejad MA, Ashrafi F. Preparation of solid lipid nanoparticles and nanostructured lipid carriers containing zeaxanthin and evaluation of physicochemical properties. Colloids Surf A Physicochem Eng Asp., 641, 128588 (2022) https://doi.org/10.1016/j.colsurfa.2022.128588.

Houacine C, Adams D, Singh KK. Impact of liquid lipid on development and stability of trimyristin nanostructured lipid carriers for oral delivery of resveratrol. J Mol Liq., 316, 113734 (2020) https://doi.org/10.1016/j.molliq.2020.113734.

Suyuti A, Hendradi E, Purwanti T. Physicochemical characteristics, entrapment efficiency, and stability of nanostructured lipid carriers loaded coenzyme Q10 with different lipid ratios. J Res Pharm., 27, 1134-42(2023) https://doi.org/10.29228/jrp.404.

Darwish MK, El-Enin AS, Mohammed KH. Optimized nanoparticles for enhanced oral bioavailability of a poorly soluble drug: solid lipid nanoparticles versus nanostructured lipid carriers. Pharm Nanotechnol., 10, 69-87 (2022) https://doi.org/10.2174/2211738510666220210110003.

Naganaidu D, Khalid ZM. ANOVA assisted variable selection in high-dimensional multicategory response data. Statistics., 11, 92-100 (2023) https://doi.org/10.13189/ms.2023.110110.

Ledeţi I, Vlase G, Vlase T, Şuta LM, Todea A, Fuliaş A. Selection of solid-state excipients for simvastatin dosage forms through thermal and nonthermal techniques. J Therm Anal Calorim., 121, 1093-102 (2015) https://doi.org/10.1007/s10973-015-4832-5.

Katkade PN, Zalte AG, Gondkar SB, Darekar AB, Amrutkar SV. Formulation, optimization, characterization and evaluation of Simvastatin loaded solid lipid nanoparticles using quality by design approach. Res J Pharm Technol., 16, 5872-7 (2023) https://doi.org/10.52711/0974-360x.2023.00951.

Elsewedy HS, Shehata TM, Almostafa MM, Soliman WE. Hypolipidemic activity of olive oil-based nanostructured lipid carrier containing atorvastatin. Nanomaterials., 12, 2160 (2022) https://doi.org/10.3390/nano12132160.

Subroto E, Andoyo R, Indiarto R. Solid lipid nanoparticles: review of the current research on encapsulation and delivery systems for active and antioxidant compounds. Antioxidants., 12, 633 (2023) https://doi.org/10.3390/antiox12030633.

Aryani NL, Siswandono S, Soeratri W, Sari DR. Experimental development and molecular docking: nanostructured lipid carriers (NLCs) of coenzyme Q10 using stearic acid and different liquid lipids as lipid matrix. Int J App Pharm., 13, 108-16 (2021) https://doi.org/10.22159/ijap.2021v13i1.39890.

Huguet-Casquero A, Moreno-Sastre M, López-Méndez TB, Gainza E, Pedraz JL. Encapsulation of oleuropein in nanostructured lipid carriers: Biocompatibility and antioxidant efficacy in lung epithelial cells. Pharmaceutics., 12, 429 (2020) https://doi.org/10.3390/pharmaceutics12050429.

D’Souza A, Shegokar R. Nanostructured lipid carriers (NLCs) for drug delivery: Role of liquid lipid (oil). Curr Drug Deliv., 18, 249-70 (2021) https://doi.org/10.2174/1567201817666200423083807.